BF
MRNA icon

BOK Financial’s Moderna MRNA Stock Holding History

BOK Financial’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51.5K Sell
736
-34
-4% -$1.76K ﹤0.01% 832
2026
Q1 		$39.1K Hold
770
– – ﹤0.01% 851
2025
Q4 		$22.7K Sell
770
-222
-22% -$6.03K ﹤0.01% 917
2025
Q3 		$25.6K Buy
992
+266
+37% +$7.42K ﹤0.01% 923
2025
Q2 		$20K Buy
726
+6
+0.8% +$158 ﹤0.01% 910
2025
Q1 		$20.4K Buy
720
+56
+8% +$1.99K ﹤0.01% 915
2024
Q4 		$28.1K Sell
664
-15,125
-96% -$723K ﹤0.01% 881
2024
Q3 		$964K Buy
15,789
+72
+0.5% +$6.61K 0.02% 448
2024
Q2 		$1.87M Sell
15,717
-853
-5% -$108K 0.03% 370
2024
Q1 		$1.75M Sell
16,570
-625
-4% -$63K 0.03% 390
2023
Q4 		$1.71M Buy
17,195
+4,572
+36% +$385K 0.03% 372
2023
Q3 		$959K Buy
12,623
+7,886
+166% +$880K 0.02% 447
2023
Q2 		$576K Sell
4,737
-10,991
-70% -$1.47M 0.01% 534
2023
Q1 		$2.42M Sell
15,728
-10,816
-41% -$1.78M 0.05% 311
2022
Q4 		$4.77M Sell
26,544
-9,688
-27% -$1.58M 0.09% 212
2022
Q3 		$4.28M Buy
36,232
+2,678
+8% +$406K 0.09% 216
2022
Q2 		$4.79M Sell
33,554
-1,455
-4% -$208K 0.09% 206
2022
Q1 		$6.03M Buy
35,009
+16,328
+87% +$2.75M 0.1% 200
2021
Q4 		$4.75M Buy
18,681
+7,052
+61% +$2.06M 0.07% 247
2021
Q3 		$4.47M Buy
+11,629
New +$4.29M 0.08% 252
2021
Q1 		$988K Buy
+7,543
New +$1.09M 0.02% 555
2020
Q1 		– Sell
-26,821
Closed -$524K – 888
2019
Q4 		$524K Sell
26,821
-10,782
-29% -$191K 0.01% 696
2019
Q3 		$598K Buy
+37,603
New +$555K 0.01% 627

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

BOK Financial's MRNA Position: Q2 2026 in Review

BOK Financial reduced its Moderna (MRNA) stake by 4.4% in Q2 2026, selling an estimated $1.76K and leaving 736 shares worth $51.5K. The position accounts for ﹤0.01% of the portfolio, ranked #832.

BOK Financial first reported a position in MRNA in Q3 2019 and has held it in 23 quarters since. The position peaked at $6.03M in Q1 2022. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • BOK Financial held 736 shares of Moderna worth $51.5K as of Q2 2026.
  • BOK Financial sold 34 Moderna shares in Q2 2026, an estimated $1.76K.
  • Moderna made up ﹤0.01% of BOK Financial's portfolio in Q2 2026, its #832 holding.
  • BOK Financial first reported a position in Moderna in Q3 2019 and has held it in 23 quarters since.
  • BOK Financial's Moderna position peaked at $6.03M in Q1 2022.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on BOK Financial's 13F filing for Q2 2026, filed 10 Aug 2026.